| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,882.22% |
Sezzle Inc Common Stock (SEZL) | 2024 | 1,940.26% |
Nuscale Power (SMR) | 2024 | 712.96% |
Avidity Biosciences (RNA) | 2024 | 385.59% |
ADMA Biologics (ADMA) | 2024 | 384.89% |
Janux Therapeutics (JANX) | 2024 | 349.44% |
Lumen Technologies (LUMN) | 2024 | 327.37% |
PureCycle Technologies (PCTTW) | 2024 | 312.28% |
Ast Spacemobile (ASTS) | 2024 | 299.15% |
Sweetgreen (SG) | 2024 | 290.52% |
IES (IESC) | 2024 | 278.09% |
BBVA Banco Frances SA ADR (BBAR) | 2024 | 271.81% |
Nextnav Acquisition (NN) | 2024 | 263.35% |
SoundHound AI (SOUN) | 2024 | 257.28% |
Grupo Financiero Galicia SA ADR (GGAL) | 2024 | 256.52% |
Argan (AGX) | 2024 | 250.43% |
Hims Hers Health (HIMS) | 2024 | 248.64% |
Banco Macro SA B ADR (BMA) | 2024 | 232.99% |
Rush Street Interactive (RSI) | 2024 | 229.02% |
Purecycle Technologies (PCT) | 2024 | 228.71% |
United States Lime & Minerals (USLM) | 2024 | 228.52% |
Longboard Pharmaceuticals (LBPH) | 2024 | 224.4% |
Powell Industries (POWL) | 2024 | 213.84% |
Vera Therapeutics (VERA) | 2024 | 212.24% |
Lemonade (LMND) | 2024 | 212.06% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
